Patients who developed a prompt IFN-γ- and IL-2-producing cellular response followed by antibody production had a mild COVID-19 course, an observation in agreement with the well-known concept that the early development of virus-specific T cells and the subsequent production of neutralizing antibodies are required for effective control of viral infections [34]. Here, IL2 is linked to viral infectious disease.